CN Patent
CN109721536B — 苯基取代的稠合三环类化合物及其用途
Assigned to Nianyan Pharmaceutical Zhuhai Co ltd · Expires 2020-11-24 · 5y expired
What this patent protects
本发明涉及一种苯基取代的稠合三环类化合物及其用途,进一步涉及包含所述化合物的药物组合物。本发明所述化合物或所述药物组合物可以用作盐皮质激素受体拮抗剂。
USPTO Abstract
本发明涉及一种苯基取代的稠合三环类化合物及其用途,进一步涉及包含所述化合物的药物组合物。本发明所述化合物或所述药物组合物可以用作盐皮质激素受体拮抗剂。
Drugs covered by this patent
- Kerendia (FINERENONE) · Bayer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.